tirzepatide and testosterone 🧬 New research presented at the Endocrine Society's 2025 meeting reveals that GLP-1 medications—like semaglutide (Ozempic), dulaglutide (Trulicity), (Mounjaro)—may do more than support weight loss and blood sugar control. These Obesity drugs may raise testosterone

Fang Y, Chen B, Gong AY, Malhotra D, Gupta R, Dworkin LD, et al

3 Results 3.1 Demographic characteristics of the study participants A total of 855 patients with T2DM were included in the present study, of whom 636 (74.39%) received injections of liraglutide, 137 (16.02%) of polyethylene glycol loxenatide, 44 (5.15%) of semaglutide, 23 (2.69%) of exenatide, 3 (0.35%) of dulaglutide, and 12 (1.40%) of lixisenatide

Semaglutide, a medication originally developed for type 2 diabetes, has shown promise in aiding weight loss by reducing appetite and calorie intake

Patients with S and Z polymorphisms have significantly lower values of free copper, not bound to ceruloplasmin, as well as an alteration of zinc homeostasis

That's a frustration we've all wanted to avoid, right

Diabetes, Obesity & Metabolism, 19(9), 1242-1251